Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 5761487, 9 pages
http://dx.doi.org/10.1155/2016/5761487
Research Article

Fate and Effect of Intravenously Infused Mesenchymal Stem Cells in a Mouse Model of Hepatic Ischemia Reperfusion Injury and Resection

1Department of Surgery, Erasmus University Medical Center, Gravendijkwal 230, 3015 CE Rotterdam, Netherlands
2Nephrology and Transplantation, Department of Internal Medicine, Erasmus University Medical Center, Gravendijkwal 230, 3015 CE Rotterdam, Netherlands

Received 5 November 2015; Revised 6 January 2016; Accepted 12 January 2016

Academic Editor: Benedetta Bussolati

Copyright © 2016 T. C. Saat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. L. Shiffman, R. S. Brown Jr., K. M. Olthoff et al., “Living donor liver transplantation: summary of a conference at The National Institutes of Health,” Liver Transplantation, vol. 8, no. 2, pp. 174–188, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Karoui, C. Penna, M. Amin-Hashem et al., “Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases,” Annals of Surgery, vol. 243, no. 1, pp. 1–7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Skullman, I. Ihse, and J. Larsson, “Influence of malnutrition on regeneration and composition of the liver in rats,” Acta Chirurgica Scandinavica, vol. 156, no. 10, pp. 717–722, 1990. View at Google Scholar · View at Scopus
  4. N. A. Timchenko, “Aging and liver regeneration,” Trends in Endocrinology and Metabolism, vol. 20, no. 4, pp. 171–176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Schindl, D. N. Redhead, K. C. H. Fearon, O. J. Garden, and S. J. Wigmore, “The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection,” Gut, vol. 54, no. 2, pp. 289–296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. Q. Zhou, L. Li, and J. Li, “Stem cells with decellularized liver scaffolds in liver regeneration and their potential clinical applications,” Liver International, vol. 35, no. 3, pp. 687–694, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Ansari, M. Bergenfeldt, B. Tingstedt, and R. Andersson, “Multimodal management of colorectal liver metastases and the effect on regeneration and outcome after liver resection,” Scandinavian Journal of Gastroenterology, vol. 47, no. 12, pp. 1460–1466, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. H. Attwa and S. A. El-Etreby, “Guide for diagnosis and treatment of hepatocellular carcinoma,” World Journal of Hepatology, vol. 7, no. 12, pp. 1632–1651, 2015. View at Publisher · View at Google Scholar
  9. A. Waghray, A. R. Murali, and K. N. Menon, “Hepatocellular carcinoma: from diagnosis to treatment,” World Journal of Hepatology, vol. 7, no. 8, pp. 1020–1029, 2015. View at Publisher · View at Google Scholar
  10. T. Karatzas, A.-A. Neri, M.-E. Baibaki, and I. A. Dontas, “Rodent models of hepatic ischemia-reperfusion injury: time and percentage-related pathophysiological mechanisms,” Journal of Surgical Research, vol. 191, no. 2, pp. 399–412, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Datta, B. J. Fuller, and B. R. Davidson, “Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models,” World Journal of Gastroenterology, vol. 19, no. 11, pp. 1683–1698, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Dahm, P. Georgiev, and P.-A. Clavien, “Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications,” American Journal of Transplantation, vol. 5, no. 11, pp. 2605–2610, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Kanazawa, Y. Fujimoto, T. Teratani et al., “Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model,” PLoS ONE, vol. 6, no. 4, Article ID e19195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Ben-Haim, S. Emre, T. M. Fishbein et al., “Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease,” Liver Transplantation, vol. 7, no. 11, pp. 948–953, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Hoogduijn, M. Roemeling-Van Rhijn, A. U. Engela et al., “Mesenchymal stem cells induce an inflammatory response after intravenous infusion,” Stem Cells and Development, vol. 22, no. 21, pp. 2825–2835, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. J. W. Lee, X. Fang, A. Krasnodembskaya, J. P. Howard, and M. A. Matthay, “Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors,” Stem Cells, vol. 29, no. 6, pp. 913–919, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Jin, G. Qiu, D. Wu et al., “Allogeneic bone marrow-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury by suppressing oxidative stress and inhibiting apoptosis in rats,” International Journal of Molecular Medicine, vol. 31, no. 6, pp. 1395–1401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. C.-K. Sun, C.-L. Chang, Y.-C. Lin et al., “Systemic administration of autologous adipose-derived mesenchymal stem cells alleviates hepatic ischemia-reperfusion injury in rats,” Critical Care Medicine, vol. 40, no. 4, pp. 1279–1290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Seki, Y. Yokoyama, H. Nagasaki, T. Kokuryo, and M. Nagino, “Adipose tissue-derived mesenchymal stem cell transplantation promotes hepatic regeneration after hepatic ischemia-reperfusion and subsequent hepatectomy in rats,” Journal of Surgical Research, vol. 178, no. 1, pp. 63–70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Kaibori, Y. Adachi, T. Shimo et al., “Stimulation of liver regeneration after hepatectomy in mice by injection of bone marrow mesenchymal stem cells via the portal vein,” Transplantation Proceedings, vol. 44, no. 4, pp. 1107–1109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. R. F. Saidi, B. Rajeshkumar, A. Shariftabrizi, K. Dresser, and O. Walter, “Human C1 inhibitor attenuates liver ischemia-reperfusion injury and promotes liver regeneration,” Journal of Surgical Research, vol. 187, no. 2, pp. 660–666, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Wang, Z. Du, J. Yan et al., “Mesenchymal stem cells promote liver regeneration and prolong survival in small-for-size liver grafts: involvement of C-Jun N-terminal kinase, cyclin D1, and NF-κB,” PLoS ONE, vol. 9, no. 12, Article ID e112532, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. R. F. Saidi, B. Rajeshkumar, A. Shariftabrizi et al., “Human adipose-derived mesenchymal stem cells attenuate liver ischemia-reperfusion injury and promote liver regeneration,” Surgery, vol. 156, no. 5, pp. 1225–1231, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Behr, M. Hekmati, A. Lucchini et al., “Evaluation of the effect of autologous mesenchymal stem cell injection in a large-animal model of bilateral kidney ischaemia reperfusion injury,” Cell Proliferation, vol. 42, no. 3, pp. 284–297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Behr, M. Hekmati, G. Fromont et al., “Intra renal arterial injection of autologous mesenchymal stem cells in an ovine model in the postischemic kidney,” Nephron Physiology, vol. 107, no. 3, pp. p65–p76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Verweij, T. M. Van Ginhoven, J. R. Mitchell et al., “Preoperative fasting protects mice against hepatic ischemia/reperfusion injury: mechanisms and effects on liver regeneration,” Liver Transplantation, vol. 17, no. 6, pp. 695–704, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Zimmermann, “Regulation of liver regeneration,” Nephrology Dialysis Transplantation, vol. 19, no. 4, supplement 4, pp. iv6–iv10, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. X.-B. Chen and M.-Q. Xu, “Primary graft dysfunction after liver transplantation,” Hepatobiliary and Pancreatic Diseases International, vol. 13, no. 2, pp. 125–137, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Morigi, M. Introna, B. Imberti et al., “Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice,” Stem Cells, vol. 26, no. 8, pp. 2075–2082, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Aurich, M. Sgodda, P. Kaltwaßer et al., “Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo,” Gut, vol. 58, no. 4, pp. 570–581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. González, E. Gonzalez-Rey, L. Rico, D. Büscher, and M. Delgado, “Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses,” Gastroenterology, vol. 136, no. 3, pp. 978–989, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Elias-Miró, M. B. Jiménez-Castro, J. Rodés, and C. Peralta, “Current knowledge on oxidative stress in hepatic ischemia/reperfusion,” Free Radical Research, vol. 47, no. 8, pp. 555–568, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. R. F. van Golen, M. J. Reiniers, P. B. Olthof, T. M. van Gulik, and M. Heger, “Sterile inflammation in hepatic ischemia/reperfusion injury: present concepts and potential therapeutics,” Journal of Gastroenterology and Hepatology, vol. 28, no. 3, pp. 394–400, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. W. A. Border and N. A. Noble, “TGF-β in kidney fibrosis: a target for gene therapy,” Kidney International, vol. 51, no. 5, pp. 1388–1396, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. E. P. Böttinger and M. Bitzer, “TGF-β signaling in renal disease,” Journal of the American Society of Nephrology, vol. 13, no. 10, pp. 2600–2610, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. H. W. Schnaper, T. Hayashida, S. C. Hubchak, and A.-C. Poncelet, “TGF-β signal transduction and mesangial cell fibrogenesis,” The American Journal of Physiology—Renal Physiology, vol. 284, no. 2, pp. F243–F252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Yu, L. Lu, X. Qian et al., “Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats,” Stem Cells and Development, vol. 19, no. 6, pp. 903–914, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Eggenhofer, V. Benseler, A. Kroemer et al., “Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion,” Frontiers in Immunology, vol. 3, article 297, Article ID Article 297, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. I. M. Barbash, P. Chouraqui, J. Baron et al., “Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution,” Circulation, vol. 108, no. 7, pp. 863–868, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. A. C. M. Assis, J. L. Carvalho, B. A. Jacoby et al., “Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart,” Cell Transplantation, vol. 19, no. 2, pp. 219–230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. U. M. Fischer, M. T. Harting, F. Jimenez et al., “Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect,” Stem Cells and Development, vol. 18, no. 5, pp. 683–691, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Chapel, J. M. Bertho, M. Bensidhoum et al., “Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome,” Journal of Gene Medicine, vol. 5, no. 12, pp. 1028–1038, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Nowacki, Ł. Nazarewski, M. Pokrywczyńska et al., “Long-term influence of bone marrow-derived mesenchymal stem cells on liver ischemia-reperfusion injury in a rat model,” Annals of Transplantation, vol. 20, pp. 132–140, 2015. View at Publisher · View at Google Scholar
  44. G.-Z. Pan, Y. Yang, J. Zhang et al., “Bone marrow mesenchymal stem cells ameliorate hepatic ischemia/reperfusion injuries via inactivation of the MEK/ERK signaling pathway in rats,” Journal of Surgical Research, vol. 178, no. 2, pp. 935–948, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Fu, H. Zhang, Y. Zhuang et al., “The role of N-acetyltransferase 8 in mesenchymal stem cell-based therapy for liver ischemia/reperfusion injury in rats,” PLoS ONE, vol. 9, no. 7, Article ID e103355, 2014. View at Publisher · View at Google Scholar · View at Scopus